About Biorelate
Biorelate is a company based in Manchester (United Kingdom) founded in 2014 by Daniel Jamieson. Biorelate has raised $8.74 million across 4 funding rounds from investors including Maven Capital Partners, Triple Point and YFM Equity Partners. Biorelate offers products and services including Galactic AI and Knowledge Graphs. Biorelate operates in a competitive market with competitors including Science Exchange, Bioz, Naicons, LIFE & BRAIN and Sciformix Corporation, among others.
- Headquarter Manchester, United Kingdom
- Founders Daniel Jamieson
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biorelate Limited
- Date of Incorporation 16 Jun, 2014
- Jurisdiction MANCHESTER, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.74 M (USD)
in 4 rounds
-
Latest Funding Round
$7.82 M (USD), Series A
Nov 29, 2022
-
Investors
Maven Capital Partners
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biorelate
Biorelate offers a comprehensive portfolio of products and services, including Galactic AI and Knowledge Graphs.
AI for curating biomedical data and relationships.
Tool for building and analyzing biomedical knowledge networks.
People of Biorelate
Unlock access to complete
Funding Insights of Biorelate
Biorelate has successfully raised a total of $8.74M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $7.82 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biorelate
Biorelate has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Maven Capital Partners, Triple Point and YFM Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Multiple sectors are targeted for private equity investments.
|
Locked | Locked | Locked | |
|
Private debt is extended to early-stage companies and SMEs.
|
Locked | Locked | Locked |
Investor details for Biorelate
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biorelate
Investment portfolio details for Biorelate
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biorelate
Detailed financials for Biorelate
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biorelate Comparisons
Peer comparison for Biorelate
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biorelate
Biorelate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Science Exchange, Bioz, Naicons, LIFE & BRAIN and Sciformix Corporation, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Scientific research is outsourced via an online marketplace platform.
|
|
| Locked | Locked | Locked |
Developer of AI search engine for scientific experimentation
|
|
| Locked | Locked | Locked |
Developer of bioactive compounds for drug-resistant bacterial infections
|
|
| Locked | Locked | Locked |
Biomedical and neuroscientific technologies are researched and developed.
|
|
| Locked | Locked | Locked |
Scientific process outsourcing is delivered for life sciences firms.
|
Detailed competitors of Biorelate
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biorelate
Complete news archive for Biorelate
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biorelate
Biorelate was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Biorelate is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
Daniel Jamieson is the current CEO of Biorelate. They have also founded this company.
Biorelate is a funded company, having raised a total of $8.74M across 4 funding rounds to date.
Founded in 2014 and based in Manchester, United Kingdom, Biorelate operates in the biotechnology sector with a focus on AI applications. An AI-driven knowledge graph is developed to support biomedical target identification, drug discovery, and validation of target lists. Tools are offered for analyzing mechanisms of action and target-drug-disease relationships. Causal insights from diverse sources are integrated to reveal undescribed connections in biomedical research.
Biorelate's top competitors include Science Exchange, Bioz and Naicons.
Biorelate offers Galactic AI and Knowledge Graphs.
Biorelate has 8 investors. Key investors include Maven Capital Partners, Triple Point, YFM Equity Partners, Northern Powerhouse Investment Fund, and Innovate UK.